The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Human Papillomavirus: Epidemiology and Public Health
Abstract
Approximately 15 types of human papillomavirus (HPV) infection cause virtually all cases of cervical cancer. Human papillomavirus 16 is the major type, accounting for approximately 50% of cases. The major steps of cervical carcinogenesis include HPV infection, viral persistence and progression to precancer (as opposed to viral clearance), and invasion. Human papillomavirus is the most common sexually transmitted infection. However, most HPV infections become undetectable by even sensitive HPV DNA testing within 1 to 2 years. The prevalence of infection peaks at young ages and declines thereafter, perhaps as the result of HPV type-specific acquired immunity. Most HPV infections are neither microscopically evident nor visible, making HPV DNA detection the diagnostic reference standard. Poorly defined immunologic factors are the major determinants of viral outcome. Smoking, multiparity, and long-term oral contraceptive use increase the risk of persistence and progression. Other sexually transmitted infections (eg, Chlamydia trachomatis ), chronic inflammation, and nutritional factors might also play a role. Overt, long-term viral persistence in the absence of precancer is uncommon. New prevention strategies can be derived from the evolving knowledge of HPV carcinogenesis. Human papillomavirus vaccination is the ultimate prevention strategy, and large-scale trials are already underway. In the meantime, HPV DNA diagnostics are more sensitive although less specific than cytology, permitting a consideration of lengthened screening intervals. In terms of public health education, clinicians and patients will need to shift discussions of the mildly abnormal Papanicolaou test to consideration of HPV infection as a common sexually transmitted infection that rarely causes cervical cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Epidemiology of Genital Human Papillomavirus Infection
Koutsky, P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,107
Stoler, M. H. (2001) · JAMA · doi:10.1001/jama.285.11.1500 · Cited by 1,087
Bauer, H. M. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460040048027 · Cited by 952
Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners
Castellsagué, X., Bosch, F. X., Muñoz, N., Meijer, C. J. L. M., Shah, K. V., de Sanjosé, S., Eluf-Neto, J., Ngelangel, C. A., Chichareon, S., Smith, J. S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011688 · Cited by 804
Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia
Ho, G. Y. F., Burk, R. D., Klein, S., Kadish, A. S., Chang, C. J., Palan, P., Basu, J., Tachezy, R., Lewis, R., & Romney, S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.18.1365 · Cited by 803
Moreno, V., Bosch, F. X., Muñoz, N., Meijer, C. J., Shah, K. V., Walboomers, J. M., Herrero, R., & Franceschi, S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08150-3 · Cited by 692
Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study
Muñoz, N., Franceschi, S., Bosetti, C., Moreno, V., Herrero, R., Smith, J. S., Shah, K. V., Meijer, C. J., & Bosch, F. X. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08151-5 · Cited by 684
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
Self-citation
Cited by
Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998
Preston, D. L., Ron, E., Tokuoka, S., Funamoto, S., Nishi, N., Soda, M., Mabuchi, K., & Kodama, K. (2007) · Radiation Research · doi:10.1667/rr0763.1 · Cited by 1,753
Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17398-4 · Cited by 1,643
The global burden of cancer: priorities for prevention
Thun, M. J., DeLancey, J. O., Center, M. M., Jemal, A., & Ward, E. M. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp263 · Cited by 1,091
The epidemiology of genital human papillomavirus infection
Trottier, H., & Franco, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.054 · Cited by 686
Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia
Trottier, H., Mahmud, S., Costa, M. C., Sobrinho, J. P., Duarte-Franco, E., Rohan, T. E., Ferenczy, A., Villa, L. L., & Franco, E. L. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0129 · Cited by 352
Metadata
- Authors
- Schiffman, M., & Castle, P. E.
- Venue
- Archives of Pathology & Laboratory Medicine
- Published
- 2003-08
- Volume
- 127
- Issue
- 8
- Pages
- 930-934
- ISSN
- 0003-9985 (ISSN-L)
- 1543-2165
- OpenAlex
- W2117555834
- Cited by
- 328
- References
- 29
- FWCI
- 13.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human Papillomavirus: Epidemiology and Public Health. https://app.cochat.ai/papers/10.5858/2003-127-930-hpeaph
- The paper
- Schiffman, M., & Castle, P. E. (2003). Human Papillomavirus: Epidemiology and Public Health. Archives of Pathology & Laboratory Medicine. https://doi.org/10.5858/2003-127-930-hpeaph
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.